RT Journal Article
SR Electronic
T1 Formation of oxidized gases and secondary organic aerosol from a commercial oxidant-generating electronic air cleaner
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.01.21258186
DO 10.1101/2021.06.01.21258186
A1 Taekyu Joo
A1 Jean C. Rivera-Rios
A1 Daniel Alvarado-Velez
A1 Sabrina Westgate
A1 Nga Lee Ng
YR 2021
UL http://medrxiv.org/content/early/2021/06/04/2021.06.01.21258186.abstract
AB Airborne virus transmission during the COVID-19 pandemic increased the demand for indoor air cleaners. While some commercial electronic air cleaners could be effective in reducing primary pollutants and inactivating bioaerosol, studies on the formation of secondary products from oxidation chemistry during their use are limited. Here, we measured oxygenated volatile organic compounds (OVOCs) and the chemical composition of particles generated from a hydroxyl radical generator in an office. During operation, enhancements in OVOCs, especially low-molecular-weight organic and inorganic acids, were detected. Rapid increases in particle number and volume concentrations were observed, corresponding to the formation of highly-oxidized secondary organic aerosol (SOA) (O:C ∼1.3). The organic mass spectra showed an enhanced signal at m/z 44 (CO2+) and the aerosol evolved with a slope of ∼ -1 in the Van Krevelen diagram. These results suggest that organic acids generated during VOC oxidation contributed to particle nucleation and SOA formation. Nitrate, sulfate, and chloride also increased during the oxidation without a corresponding increase in ammonium, suggesting organic nitrate, organic sulfate, and organic chloride formation. As secondary species are reported to have detrimental health effects, further studies are needed to evaluate potential OVOCs and SOA formation from electronic air cleaners in different indoor environments.Synopsis We observed formation of oxygenated volatile organic compounds and secondary organic aerosol from an electronic air cleaner.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe HR-ToF-CIMS was purchased through NSF Major Research Instrumentation (MRI) grant 1428738Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study did not involve human subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the main text or the supporting information.